|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Trivascular Technologies, Inc. (TRIV) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
19,330,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$5.31 - $5.31 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Roeder Douglas A |
Director |
– • • |
2016-02-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,535,910) |
0 |
|
- |
|
| Roeder Douglas A |
Director |
– • • |
2016-02-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(149) |
0 |
|
- |
|
| Pakianathan Deepika |
10% Owner |
– – • |
2016-02-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,535,910) |
0 |
|
- |
|
| Sandell Scott D |
10% Owner |
– – • |
2016-02-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,943,269) |
0 |
|
- |
|
| Chavez Christopher G |
President, CEO and Chairman |
• • – |
2016-02-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(728,561) |
0 |
|
- |
|
| Chavez Christopher G |
President, CEO and Chairman |
• • – |
2016-02-03 |
4 |
D |
$5.62 |
$251,293 |
D/D |
(44,714) |
668,393 |
|
- |
|
| Chavez Christopher G |
President, CEO and Chairman |
• • – |
2016-02-03 |
4 |
OE |
$0.00 |
$96,590 |
D/D |
113,323 |
689,672 |
|
- |
|
| Elting Kimberley A. |
VP, Gen. Counsel and Secretary |
• – – |
2016-02-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(40,207) |
0 |
|
- |
|
| Elting Kimberley A. |
VP, Gen. Counsel and Secretary |
• – – |
2016-02-03 |
4 |
D |
$5.62 |
$227,795 |
D/D |
(40,533) |
30,105 |
|
- |
|
| Elting Kimberley A. |
VP, Gen. Counsel and Secretary |
• – – |
2016-02-03 |
4 |
OE |
$0.00 |
$200,268 |
D/D |
76,621 |
65,740 |
|
- |
|
| Jayaraman Vivek K |
VP Global Sales and Marketing |
• – – |
2016-02-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(40,322) |
0 |
|
- |
|
| Jayaraman Vivek K |
VP Global Sales and Marketing |
• – – |
2016-02-03 |
4 |
D |
$5.62 |
$146,828 |
D/D |
(26,126) |
33,351 |
|
- |
|
| Jayaraman Vivek K |
VP Global Sales and Marketing |
• – – |
2016-02-03 |
4 |
OE |
$0.00 |
$116,101 |
D/D |
60,178 |
54,048 |
|
- |
|
| Kramer Michael R |
Chief Financial Officer |
• – – |
2016-02-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(109,542) |
0 |
|
- |
|
| Kramer Michael R |
Chief Financial Officer |
• – – |
2016-02-03 |
4 |
D |
$5.62 |
$77,550 |
D/D |
(13,799) |
101,103 |
|
- |
|
| Kramer Michael R |
Chief Financial Officer |
• – – |
2016-02-03 |
4 |
OE |
$0.00 |
$38,958 |
D/D |
31,032 |
108,341 |
|
- |
|
| Thomas Robert |
|
– • – |
2016-02-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(99,494) |
0 |
|
- |
|
| Thomas Robert |
|
– • – |
2016-02-03 |
4 |
D |
$5.62 |
$40,155 |
D/D |
(7,145) |
99,494 |
|
- |
|
| Thomas Robert |
|
– • – |
2016-02-03 |
4 |
OE |
$2.43 |
$40,151 |
D/D |
16,523 |
106,639 |
|
- |
|
| Moore Daniel Jeffrey |
|
– • – |
2016-02-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,889) |
0 |
|
- |
|
| Moore Daniel Jeffrey |
|
– • – |
2016-02-03 |
4 |
D |
$5.62 |
$38,059 |
D/D |
(6,772) |
8,889 |
|
- |
|
| Moore Daniel Jeffrey |
|
– • – |
2016-02-03 |
4 |
OE |
$2.43 |
$38,056 |
D/D |
15,661 |
15,661 |
|
- |
|
| Oquinn Shari L |
VP Clinical/Regulatory Affairs |
• – – |
2016-02-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(29,597) |
0 |
|
- |
|
| Oquinn Shari L |
VP Clinical/Regulatory Affairs |
• – – |
2016-02-03 |
4 |
D |
$5.62 |
$121,622 |
D/D |
(21,641) |
23,746 |
|
- |
|
| Oquinn Shari L |
VP Clinical/Regulatory Affairs |
• – – |
2016-02-03 |
4 |
OE |
$0.00 |
$101,666 |
D/D |
51,238 |
41,838 |
|
- |
|
29 Records found
|
|
Page 1 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
